Development of new endoscopic irreversible electroporation ablation device: Animal experimental study

Date 28 June 2017
Event ESMO World Congress on Gastrointestinal Cancer 2017
Session ESMO World Congress on Gastrointestinal Cancer 2017
Topics Gastrointestinal Cancers
Surgery and/or Radiotherapy of Cancer
Presenter Geeho Min
Citation Annals of Oncology (2017) 28 (suppl_3): iii13-iii136. 10.1093/annonc/mdx261
Authors G. Min, J. Choi Seong, Y. Lee Sang, H.J. Chun, M. Lee Jung, K. Yoo In, M. Lee Jae, H. Kim Seung, S. Choi Hyuk, S. Kim Eun, B. Keum, Y.T. Jeen, S. Lee Hong, D. Kim Chang
  • /

Abstract

Irreversible electroporation (IRE) is a promising novel technique for the ablation of tumors. An advantage of IRE is its mechanism to remove undesired cells by affecting the cell membrane without thermally destructing blood vessels, nerves and the surrounding tissues. Several clinical trials for applying IRE to human organs such as liver, pancreas, and kidney are conducted and studies about IRE ablation for gastrointestinal tumors also have been conducted recently. Here, we developed new endoscopic IRE device, and studied about its effectiveness and feasibility in animal model.